Methods: Institutional based cross-sectional study was conducted from February, 2014 to April, 2015 in Arsi University ATH. We screened all volunteers ATH staff with HBsAg (Intec products INC (XIAMEN) China) and offered them complete dose of HBV vaccine for those HBsAg test negative individuals. Demo-graphic information of participants was documented on laboratory registration book during screening. The study was ethical cleared by Institutional review broad (IRB) of Arsi University College of Health Science. All analyses were performed by using SPSS version 20.
Results: 643 staff of ATH who volunteered were screened for HBsAg from serum. The mean age of the participant’s 32 years and 59.1% of them were females. The total prevalence of HBsAg was 6.4% (41/643) and it was 5.8% (12/207), 5.9 % (20/338), 6.7% (2/30), 7.7% (2/26), 9% (1/11), and 12.9% (4/31) among nurse and mid-wife, administration, physician, laboratory personnel, pharmacy, and non-health professional (cleaners or loader workers) respectively. The prevalence also high between the age 19-30 years old 7.5% (28/372) and >50 years old 7.4% (2/27). The compliance of the staff for HBV vaccine was 93.6%.
Conclusion: The sero-prevalence of HBV was not significantly different between HCWs and administration staff; this might be because of health professionals those know their HBV infection sero status or got vaccine not participated in the study. The prevalence was high among non-professional HCWs at the study area. The priority of infection prevention and control training, and health education should be given to them. We also highly recommend screening of all health care providers and provision of hepatitis B vaccine.
T. B. Tufa,
D. Garoma, None